Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001727135 | SCV001962251 | uncertain significance | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | FBXO11: PP2 |
Labcorp Genetics |
RCV001727135 | SCV002332015 | benign | not provided | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002539767 | SCV003700920 | likely benign | Inborn genetic diseases | 2022-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |